Ascendis Pharma A/S vs BridgeBio Pharma
ASND and BBIO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASND and BBIO compare
BridgeBio Pharma grew revenue faster over the last twelve months (167% versus 113% for Ascendis Pharma A/S).
Ascendis Pharma A/S scores higher on the StockData Score (7 against 3 for BridgeBio Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASND | BBIO |
|---|---|---|
| Size and price | ||
| Market cap | – | $14.7B |
| Share price | $251.27 | $74.95 |
| Change, 1 year | 22.1% | 12.5% |
| Change, 5 years | 56.4% | 40.3% |
| Beta (5Y) | 0.77 | 1.13 |
| Employees | 879 | 834 |
| StockData Score | ||
| Total score | 7 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 2 (better) | 0 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 15.5× |
| FCF yield | – | −2.5% |
| Growth | ||
| Revenue growth (TTM) | 113% | 167% (better) |
| Revenue growth, 5Y average | 153% (better) | 127% |
| Profitability | ||
| Gross margin | 91.3% | 94.3% (better) |
| Operating margin | 25.4% (better) | −38.5% |
| Net margin | 70.8% | – |
| FCF margin | – | −39.1% |
| Financial health | ||
| Net debt / EBITDA | −1.61 | – |
| Interest coverage | 1.3× (better) | −7.1× |
| Current ratio | 2.99 (better) | 2.09 |
| Altman Z-score | – | 0.06 |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Buyback yield | – | 1.7% |
| Shareholder yield | – | 1.7% |
| Ownership | ||
| Held by institutions | 108% | 99.1% |
| Held by insiders | 0.83% | 35.5% |
| Insider net buying, 12 months | −$4.7M (better) | −$105M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 15.6% |
Go deeper
- ASND stock overview
- ASND income statement
- ASND valuation and score
- BBIO stock overview
- BBIO income statement
- BBIO valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.